nodes	percent_of_prediction	percent_of_DWPC	metapath
Timolol—CYP2D6—Hydroxyurea—psoriasis	0.0704	0.128	CbGbCtD
Timolol—CYP2C19—Cholecalciferol—psoriasis	0.0561	0.102	CbGbCtD
Timolol—CYP2D6—Cholecalciferol—psoriasis	0.0427	0.0776	CbGbCtD
Timolol—ABCB1—Mycophenolate mofetil—psoriasis	0.0393	0.0714	CbGbCtD
Timolol—CYP2C19—Prednisone—psoriasis	0.0389	0.0707	CbGbCtD
Timolol—CYP2C19—Cyclosporine—psoriasis	0.0369	0.0671	CbGbCtD
Timolol—ABCB1—Betamethasone—psoriasis	0.0337	0.0613	CbGbCtD
Timolol—ABCB1—Prednisolone—psoriasis	0.0332	0.0604	CbGbCtD
Timolol—ABCB1—Hydrocortisone—psoriasis	0.0315	0.0573	CbGbCtD
Timolol—ABCB1—Prednisone—psoriasis	0.0314	0.0571	CbGbCtD
Timolol—ABCB1—Cyclosporine—psoriasis	0.0298	0.0541	CbGbCtD
Timolol—CYP2D6—Cyclosporine—psoriasis	0.028	0.051	CbGbCtD
Timolol—CYP2C19—Dexamethasone—psoriasis	0.0243	0.0442	CbGbCtD
Timolol—ABCB1—Dexamethasone—psoriasis	0.0196	0.0356	CbGbCtD
Timolol—CYP2D6—Dexamethasone—psoriasis	0.0185	0.0336	CbGbCtD
Timolol—ABCB1—Methotrexate—psoriasis	0.0157	0.0286	CbGbCtD
Timolol—CYP2C19—CYP2E1 reactions—CYP2S1—psoriasis	0.000183	0.081	CbGpPWpGaD
Timolol—CYP2D6—CYP2E1 reactions—CYP2S1—psoriasis	0.000168	0.0745	CbGpPWpGaD
Timolol—CYP2D6—Miscellaneous substrates—CYP2S1—psoriasis	0.000157	0.0695	CbGpPWpGaD
Timolol—Mental disorder—Prednisone—psoriasis	0.000135	0.000302	CcSEcCtD
Timolol—Erythema—Prednisone—psoriasis	0.000135	0.0003	CcSEcCtD
Timolol—Malnutrition—Prednisone—psoriasis	0.000135	0.0003	CcSEcCtD
Timolol—Musculoskeletal discomfort—Hydrocortisone—psoriasis	0.000134	0.0003	CcSEcCtD
Timolol—Hyperhidrosis—Triamcinolone—psoriasis	0.000134	0.0003	CcSEcCtD
Timolol—Agranulocytosis—Methotrexate—psoriasis	0.000134	0.0003	CcSEcCtD
Timolol—Feeling abnormal—Mycophenolate mofetil—psoriasis	0.000133	0.000298	CcSEcCtD
Timolol—Insomnia—Hydrocortisone—psoriasis	0.000133	0.000298	CcSEcCtD
Timolol—Hypertension—Dexamethasone—psoriasis	0.000133	0.000298	CcSEcCtD
Timolol—Hypertension—Betamethasone—psoriasis	0.000133	0.000298	CcSEcCtD
Timolol—Paraesthesia—Hydrocortisone—psoriasis	0.000132	0.000296	CcSEcCtD
Timolol—Gastrointestinal pain—Mycophenolate mofetil—psoriasis	0.000132	0.000296	CcSEcCtD
Timolol—Urticaria—Cyclosporine—psoriasis	0.000132	0.000295	CcSEcCtD
Timolol—Myalgia—Dexamethasone—psoriasis	0.000131	0.000294	CcSEcCtD
Timolol—Myalgia—Betamethasone—psoriasis	0.000131	0.000294	CcSEcCtD
Timolol—Abdominal pain—Cyclosporine—psoriasis	0.000131	0.000293	CcSEcCtD
Timolol—Body temperature increased—Cyclosporine—psoriasis	0.000131	0.000293	CcSEcCtD
Timolol—Anxiety—Dexamethasone—psoriasis	0.000131	0.000293	CcSEcCtD
Timolol—Anxiety—Betamethasone—psoriasis	0.000131	0.000293	CcSEcCtD
Timolol—Vomiting—Mycophenolic acid—psoriasis	0.00013	0.000291	CcSEcCtD
Timolol—Discomfort—Betamethasone—psoriasis	0.00013	0.00029	CcSEcCtD
Timolol—Discomfort—Dexamethasone—psoriasis	0.00013	0.00029	CcSEcCtD
Timolol—Dyspepsia—Hydrocortisone—psoriasis	0.00013	0.00029	CcSEcCtD
Timolol—Rash—Mycophenolic acid—psoriasis	0.000129	0.000289	CcSEcCtD
Timolol—Dermatitis—Mycophenolic acid—psoriasis	0.000129	0.000289	CcSEcCtD
Timolol—Pain—Prednisolone—psoriasis	0.000129	0.000288	CcSEcCtD
Timolol—Urticaria—Mycophenolate mofetil—psoriasis	0.000129	0.000287	CcSEcCtD
Timolol—Headache—Mycophenolic acid—psoriasis	0.000129	0.000287	CcSEcCtD
Timolol—Decreased appetite—Hydrocortisone—psoriasis	0.000128	0.000286	CcSEcCtD
Timolol—Abdominal pain—Mycophenolate mofetil—psoriasis	0.000128	0.000286	CcSEcCtD
Timolol—Body temperature increased—Mycophenolate mofetil—psoriasis	0.000128	0.000286	CcSEcCtD
Timolol—Gastrointestinal disorder—Hydrocortisone—psoriasis	0.000127	0.000284	CcSEcCtD
Timolol—Fatigue—Hydrocortisone—psoriasis	0.000127	0.000284	CcSEcCtD
Timolol—Vision blurred—Prednisone—psoriasis	0.000127	0.000283	CcSEcCtD
Timolol—Musculoskeletal discomfort—Triamcinolone—psoriasis	0.000127	0.000283	CcSEcCtD
Timolol—Pain—Hydrocortisone—psoriasis	0.000126	0.000282	CcSEcCtD
Timolol—Anaphylactic shock—Dexamethasone—psoriasis	0.000126	0.000281	CcSEcCtD
Timolol—Oedema—Dexamethasone—psoriasis	0.000126	0.000281	CcSEcCtD
Timolol—Anaphylactic shock—Betamethasone—psoriasis	0.000126	0.000281	CcSEcCtD
Timolol—Oedema—Betamethasone—psoriasis	0.000126	0.000281	CcSEcCtD
Timolol—Insomnia—Triamcinolone—psoriasis	0.000126	0.000281	CcSEcCtD
Timolol—Infection—Dexamethasone—psoriasis	0.000125	0.00028	CcSEcCtD
Timolol—Infection—Betamethasone—psoriasis	0.000125	0.00028	CcSEcCtD
Timolol—Paraesthesia—Triamcinolone—psoriasis	0.000125	0.000279	CcSEcCtD
Timolol—Feeling abnormal—Prednisolone—psoriasis	0.000124	0.000278	CcSEcCtD
Timolol—Visual impairment—Methotrexate—psoriasis	0.000124	0.000278	CcSEcCtD
Timolol—Shock—Dexamethasone—psoriasis	0.000124	0.000277	CcSEcCtD
Timolol—Shock—Betamethasone—psoriasis	0.000124	0.000277	CcSEcCtD
Timolol—Dyspnoea—Triamcinolone—psoriasis	0.000124	0.000277	CcSEcCtD
Timolol—Nervous system disorder—Betamethasone—psoriasis	0.000124	0.000276	CcSEcCtD
Timolol—Nervous system disorder—Dexamethasone—psoriasis	0.000124	0.000276	CcSEcCtD
Timolol—Angioedema—Prednisone—psoriasis	0.000123	0.000274	CcSEcCtD
Timolol—Hypersensitivity—Cyclosporine—psoriasis	0.000122	0.000273	CcSEcCtD
Timolol—Dyspepsia—Triamcinolone—psoriasis	0.000122	0.000273	CcSEcCtD
Timolol—Nausea—Mycophenolic acid—psoriasis	0.000122	0.000272	CcSEcCtD
Timolol—Hyperhidrosis—Betamethasone—psoriasis	0.000122	0.000272	CcSEcCtD
Timolol—Hyperhidrosis—Dexamethasone—psoriasis	0.000122	0.000272	CcSEcCtD
Timolol—Feeling abnormal—Hydrocortisone—psoriasis	0.000122	0.000271	CcSEcCtD
Timolol—Vertigo—Prednisone—psoriasis	0.000121	0.00027	CcSEcCtD
Timolol—Eye disorder—Methotrexate—psoriasis	0.000121	0.000269	CcSEcCtD
Timolol—Gastrointestinal pain—Hydrocortisone—psoriasis	0.000121	0.000269	CcSEcCtD
Timolol—Syncope—Prednisone—psoriasis	0.000121	0.000269	CcSEcCtD
Timolol—Tinnitus—Methotrexate—psoriasis	0.00012	0.000269	CcSEcCtD
Timolol—Anorexia—Dexamethasone—psoriasis	0.00012	0.000268	CcSEcCtD
Timolol—Anorexia—Betamethasone—psoriasis	0.00012	0.000268	CcSEcCtD
Timolol—Urticaria—Prednisolone—psoriasis	0.00012	0.000268	CcSEcCtD
Timolol—Cardiac disorder—Methotrexate—psoriasis	0.00012	0.000268	CcSEcCtD
Timolol—Fatigue—Triamcinolone—psoriasis	0.00012	0.000267	CcSEcCtD
Timolol—Hypersensitivity—Mycophenolate mofetil—psoriasis	0.000119	0.000266	CcSEcCtD
Timolol—Asthenia—Cyclosporine—psoriasis	0.000119	0.000266	CcSEcCtD
Timolol—Pain—Triamcinolone—psoriasis	0.000119	0.000265	CcSEcCtD
Timolol—Loss of consciousness—Prednisone—psoriasis	0.000118	0.000264	CcSEcCtD
Timolol—Hypotension—Betamethasone—psoriasis	0.000118	0.000263	CcSEcCtD
Timolol—Hypotension—Dexamethasone—psoriasis	0.000118	0.000263	CcSEcCtD
Timolol—Pruritus—Cyclosporine—psoriasis	0.000117	0.000262	CcSEcCtD
Timolol—Urticaria—Hydrocortisone—psoriasis	0.000117	0.000262	CcSEcCtD
Timolol—Angiopathy—Methotrexate—psoriasis	0.000117	0.000262	CcSEcCtD
Timolol—Immune system disorder—Methotrexate—psoriasis	0.000117	0.00026	CcSEcCtD
Timolol—Abdominal pain—Hydrocortisone—psoriasis	0.000117	0.00026	CcSEcCtD
Timolol—Body temperature increased—Hydrocortisone—psoriasis	0.000117	0.00026	CcSEcCtD
Timolol—Mediastinal disorder—Methotrexate—psoriasis	0.000116	0.00026	CcSEcCtD
Timolol—Asthenia—Mycophenolate mofetil—psoriasis	0.000116	0.000259	CcSEcCtD
Timolol—Hypertension—Prednisone—psoriasis	0.000116	0.000259	CcSEcCtD
Timolol—Musculoskeletal discomfort—Betamethasone—psoriasis	0.000115	0.000256	CcSEcCtD
Timolol—Musculoskeletal discomfort—Dexamethasone—psoriasis	0.000115	0.000256	CcSEcCtD
Timolol—Pruritus—Mycophenolate mofetil—psoriasis	0.000115	0.000256	CcSEcCtD
Timolol—Myalgia—Prednisone—psoriasis	0.000115	0.000256	CcSEcCtD
Timolol—Arthralgia—Prednisone—psoriasis	0.000115	0.000256	CcSEcCtD
Timolol—Feeling abnormal—Triamcinolone—psoriasis	0.000114	0.000256	CcSEcCtD
Timolol—Anxiety—Prednisone—psoriasis	0.000114	0.000255	CcSEcCtD
Timolol—Alopecia—Methotrexate—psoriasis	0.000114	0.000255	CcSEcCtD
Timolol—Insomnia—Dexamethasone—psoriasis	0.000114	0.000255	CcSEcCtD
Timolol—Insomnia—Betamethasone—psoriasis	0.000114	0.000255	CcSEcCtD
Timolol—Unspecified disorder of skin and subcutaneous tissue—Prednisone—psoriasis	0.000114	0.000254	CcSEcCtD
Timolol—Diarrhoea—Cyclosporine—psoriasis	0.000114	0.000254	CcSEcCtD
Timolol—CYP2C19—Xenobiotics—CYP2S1—psoriasis	0.000113	0.0502	CbGpPWpGaD
Timolol—Paraesthesia—Betamethasone—psoriasis	0.000113	0.000253	CcSEcCtD
Timolol—Paraesthesia—Dexamethasone—psoriasis	0.000113	0.000253	CcSEcCtD
Timolol—Discomfort—Prednisone—psoriasis	0.000113	0.000253	CcSEcCtD
Timolol—Mental disorder—Methotrexate—psoriasis	0.000113	0.000253	CcSEcCtD
Timolol—Malnutrition—Methotrexate—psoriasis	0.000112	0.000251	CcSEcCtD
Timolol—Erythema—Methotrexate—psoriasis	0.000112	0.000251	CcSEcCtD
Timolol—Hypersensitivity—Prednisolone—psoriasis	0.000111	0.000249	CcSEcCtD
Timolol—Dyspepsia—Betamethasone—psoriasis	0.000111	0.000248	CcSEcCtD
Timolol—Dyspepsia—Dexamethasone—psoriasis	0.000111	0.000248	CcSEcCtD
Timolol—Diarrhoea—Mycophenolate mofetil—psoriasis	0.000111	0.000247	CcSEcCtD
Timolol—Urticaria—Triamcinolone—psoriasis	0.00011	0.000246	CcSEcCtD
Timolol—Dysgeusia—Methotrexate—psoriasis	0.00011	0.000246	CcSEcCtD
Timolol—Body temperature increased—Triamcinolone—psoriasis	0.00011	0.000245	CcSEcCtD
Timolol—Dizziness—Cyclosporine—psoriasis	0.00011	0.000245	CcSEcCtD
Timolol—Oedema—Prednisone—psoriasis	0.00011	0.000245	CcSEcCtD
Timolol—Anaphylactic shock—Prednisone—psoriasis	0.00011	0.000245	CcSEcCtD
Timolol—Decreased appetite—Dexamethasone—psoriasis	0.00011	0.000245	CcSEcCtD
Timolol—Decreased appetite—Betamethasone—psoriasis	0.00011	0.000245	CcSEcCtD
Timolol—Infection—Prednisone—psoriasis	0.000109	0.000244	CcSEcCtD
Timolol—Gastrointestinal disorder—Dexamethasone—psoriasis	0.000109	0.000243	CcSEcCtD
Timolol—Gastrointestinal disorder—Betamethasone—psoriasis	0.000109	0.000243	CcSEcCtD
Timolol—Hypersensitivity—Hydrocortisone—psoriasis	0.000109	0.000243	CcSEcCtD
Timolol—Fatigue—Dexamethasone—psoriasis	0.000109	0.000243	CcSEcCtD
Timolol—Fatigue—Betamethasone—psoriasis	0.000109	0.000243	CcSEcCtD
Timolol—Shock—Prednisone—psoriasis	0.000108	0.000241	CcSEcCtD
Timolol—Pain—Dexamethasone—psoriasis	0.000108	0.000241	CcSEcCtD
Timolol—Pain—Betamethasone—psoriasis	0.000108	0.000241	CcSEcCtD
Timolol—Nervous system disorder—Prednisone—psoriasis	0.000108	0.00024	CcSEcCtD
Timolol—Dizziness—Mycophenolate mofetil—psoriasis	0.000107	0.000239	CcSEcCtD
Timolol—Skin disorder—Prednisone—psoriasis	0.000107	0.000238	CcSEcCtD
Timolol—Hyperhidrosis—Prednisone—psoriasis	0.000106	0.000237	CcSEcCtD
Timolol—Vision blurred—Methotrexate—psoriasis	0.000106	0.000237	CcSEcCtD
Timolol—Asthenia—Hydrocortisone—psoriasis	0.000106	0.000236	CcSEcCtD
Timolol—Vomiting—Cyclosporine—psoriasis	0.000106	0.000236	CcSEcCtD
Timolol—Rash—Cyclosporine—psoriasis	0.000105	0.000234	CcSEcCtD
Timolol—Anorexia—Prednisone—psoriasis	0.000105	0.000234	CcSEcCtD
Timolol—Dermatitis—Cyclosporine—psoriasis	0.000105	0.000234	CcSEcCtD
Timolol—Pruritus—Hydrocortisone—psoriasis	0.000104	0.000233	CcSEcCtD
Timolol—CYP2D6—Xenobiotics—CYP2S1—psoriasis	0.000104	0.0462	CbGpPWpGaD
Timolol—Headache—Cyclosporine—psoriasis	0.000104	0.000232	CcSEcCtD
Timolol—Feeling abnormal—Betamethasone—psoriasis	0.000104	0.000232	CcSEcCtD
Timolol—Feeling abnormal—Dexamethasone—psoriasis	0.000104	0.000232	CcSEcCtD
Timolol—Gastrointestinal pain—Betamethasone—psoriasis	0.000103	0.00023	CcSEcCtD
Timolol—Gastrointestinal pain—Dexamethasone—psoriasis	0.000103	0.00023	CcSEcCtD
Timolol—Vomiting—Mycophenolate mofetil—psoriasis	0.000103	0.00023	CcSEcCtD
Timolol—Hypersensitivity—Triamcinolone—psoriasis	0.000102	0.000229	CcSEcCtD
Timolol—Rash—Mycophenolate mofetil—psoriasis	0.000102	0.000228	CcSEcCtD
Timolol—Dermatitis—Mycophenolate mofetil—psoriasis	0.000102	0.000228	CcSEcCtD
Timolol—Headache—Mycophenolate mofetil—psoriasis	0.000101	0.000227	CcSEcCtD
Timolol—Vertigo—Methotrexate—psoriasis	0.000101	0.000226	CcSEcCtD
Timolol—Diarrhoea—Hydrocortisone—psoriasis	0.000101	0.000225	CcSEcCtD
Timolol—Urticaria—Dexamethasone—psoriasis	0.0001	0.000224	CcSEcCtD
Timolol—Urticaria—Betamethasone—psoriasis	0.0001	0.000224	CcSEcCtD
Timolol—Musculoskeletal discomfort—Prednisone—psoriasis	0.0001	0.000223	CcSEcCtD
Timolol—Dizziness—Prednisolone—psoriasis	9.99e-05	0.000223	CcSEcCtD
Timolol—Asthenia—Triamcinolone—psoriasis	9.97e-05	0.000223	CcSEcCtD
Timolol—Body temperature increased—Dexamethasone—psoriasis	9.96e-05	0.000223	CcSEcCtD
Timolol—Abdominal pain—Betamethasone—psoriasis	9.96e-05	0.000223	CcSEcCtD
Timolol—Abdominal pain—Dexamethasone—psoriasis	9.96e-05	0.000223	CcSEcCtD
Timolol—Body temperature increased—Betamethasone—psoriasis	9.96e-05	0.000223	CcSEcCtD
Timolol—Insomnia—Prednisone—psoriasis	9.93e-05	0.000222	CcSEcCtD
Timolol—Nausea—Cyclosporine—psoriasis	9.86e-05	0.00022	CcSEcCtD
Timolol—Paraesthesia—Prednisone—psoriasis	9.86e-05	0.00022	CcSEcCtD
Timolol—Pruritus—Triamcinolone—psoriasis	9.83e-05	0.000219	CcSEcCtD
Timolol—Cough—Methotrexate—psoriasis	9.81e-05	0.000219	CcSEcCtD
Timolol—Dizziness—Hydrocortisone—psoriasis	9.76e-05	0.000218	CcSEcCtD
Timolol—Dyspepsia—Prednisone—psoriasis	9.66e-05	0.000216	CcSEcCtD
Timolol—Nausea—Mycophenolate mofetil—psoriasis	9.62e-05	0.000215	CcSEcCtD
Timolol—Arthralgia—Methotrexate—psoriasis	9.57e-05	0.000214	CcSEcCtD
Timolol—Myalgia—Methotrexate—psoriasis	9.57e-05	0.000214	CcSEcCtD
Timolol—Chest pain—Methotrexate—psoriasis	9.57e-05	0.000214	CcSEcCtD
Timolol—Decreased appetite—Prednisone—psoriasis	9.54e-05	0.000213	CcSEcCtD
Timolol—Rash—Prednisolone—psoriasis	9.52e-05	0.000213	CcSEcCtD
Timolol—Dermatitis—Prednisolone—psoriasis	9.52e-05	0.000213	CcSEcCtD
Timolol—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—psoriasis	9.5e-05	0.000212	CcSEcCtD
Timolol—Fatigue—Prednisone—psoriasis	9.46e-05	0.000211	CcSEcCtD
Timolol—Headache—Prednisolone—psoriasis	9.46e-05	0.000211	CcSEcCtD
Timolol—Discomfort—Methotrexate—psoriasis	9.46e-05	0.000211	CcSEcCtD
Timolol—Vomiting—Hydrocortisone—psoriasis	9.38e-05	0.000209	CcSEcCtD
Timolol—Rash—Hydrocortisone—psoriasis	9.3e-05	0.000208	CcSEcCtD
Timolol—Dermatitis—Hydrocortisone—psoriasis	9.29e-05	0.000208	CcSEcCtD
Timolol—Confusional state—Methotrexate—psoriasis	9.25e-05	0.000207	CcSEcCtD
Timolol—Headache—Hydrocortisone—psoriasis	9.24e-05	0.000206	CcSEcCtD
Timolol—Dizziness—Triamcinolone—psoriasis	9.19e-05	0.000205	CcSEcCtD
Timolol—Anaphylactic shock—Methotrexate—psoriasis	9.17e-05	0.000205	CcSEcCtD
Timolol—Infection—Methotrexate—psoriasis	9.11e-05	0.000204	CcSEcCtD
Timolol—Feeling abnormal—Prednisone—psoriasis	9.05e-05	0.000202	CcSEcCtD
Timolol—Asthenia—Dexamethasone—psoriasis	9.04e-05	0.000202	CcSEcCtD
Timolol—Asthenia—Betamethasone—psoriasis	9.04e-05	0.000202	CcSEcCtD
Timolol—Nervous system disorder—Methotrexate—psoriasis	9e-05	0.000201	CcSEcCtD
Timolol—Gastrointestinal pain—Prednisone—psoriasis	8.98e-05	0.0002	CcSEcCtD
Timolol—Nausea—Prednisolone—psoriasis	8.97e-05	0.0002	CcSEcCtD
Timolol—Pruritus—Dexamethasone—psoriasis	8.92e-05	0.000199	CcSEcCtD
Timolol—Pruritus—Betamethasone—psoriasis	8.92e-05	0.000199	CcSEcCtD
Timolol—Skin disorder—Methotrexate—psoriasis	8.91e-05	0.000199	CcSEcCtD
Timolol—ABCB1—Allograft Rejection—IL22—psoriasis	8.89e-05	0.0393	CbGpPWpGaD
Timolol—Hyperhidrosis—Methotrexate—psoriasis	8.87e-05	0.000198	CcSEcCtD
Timolol—Vomiting—Triamcinolone—psoriasis	8.83e-05	0.000197	CcSEcCtD
Timolol—Nausea—Hydrocortisone—psoriasis	8.76e-05	0.000196	CcSEcCtD
Timolol—Rash—Triamcinolone—psoriasis	8.76e-05	0.000196	CcSEcCtD
Timolol—Dermatitis—Triamcinolone—psoriasis	8.75e-05	0.000195	CcSEcCtD
Timolol—Anorexia—Methotrexate—psoriasis	8.74e-05	0.000195	CcSEcCtD
Timolol—Urticaria—Prednisone—psoriasis	8.72e-05	0.000195	CcSEcCtD
Timolol—Headache—Triamcinolone—psoriasis	8.7e-05	0.000194	CcSEcCtD
Timolol—Body temperature increased—Prednisone—psoriasis	8.68e-05	0.000194	CcSEcCtD
Timolol—Abdominal pain—Prednisone—psoriasis	8.68e-05	0.000194	CcSEcCtD
Timolol—Diarrhoea—Betamethasone—psoriasis	8.62e-05	0.000193	CcSEcCtD
Timolol—Diarrhoea—Dexamethasone—psoriasis	8.62e-05	0.000193	CcSEcCtD
Timolol—Hypotension—Methotrexate—psoriasis	8.57e-05	0.000191	CcSEcCtD
Timolol—Musculoskeletal discomfort—Methotrexate—psoriasis	8.36e-05	0.000187	CcSEcCtD
Timolol—Dizziness—Betamethasone—psoriasis	8.34e-05	0.000186	CcSEcCtD
Timolol—Dizziness—Dexamethasone—psoriasis	8.34e-05	0.000186	CcSEcCtD
Timolol—Insomnia—Methotrexate—psoriasis	8.3e-05	0.000185	CcSEcCtD
Timolol—Nausea—Triamcinolone—psoriasis	8.25e-05	0.000184	CcSEcCtD
Timolol—Paraesthesia—Methotrexate—psoriasis	8.24e-05	0.000184	CcSEcCtD
Timolol—Dyspnoea—Methotrexate—psoriasis	8.18e-05	0.000183	CcSEcCtD
Timolol—Somnolence—Methotrexate—psoriasis	8.16e-05	0.000182	CcSEcCtD
Timolol—Hypersensitivity—Prednisone—psoriasis	8.09e-05	0.000181	CcSEcCtD
Timolol—Dyspepsia—Methotrexate—psoriasis	8.08e-05	0.00018	CcSEcCtD
Timolol—Vomiting—Betamethasone—psoriasis	8.01e-05	0.000179	CcSEcCtD
Timolol—Vomiting—Dexamethasone—psoriasis	8.01e-05	0.000179	CcSEcCtD
Timolol—Decreased appetite—Methotrexate—psoriasis	7.97e-05	0.000178	CcSEcCtD
Timolol—Rash—Betamethasone—psoriasis	7.95e-05	0.000177	CcSEcCtD
Timolol—Rash—Dexamethasone—psoriasis	7.95e-05	0.000177	CcSEcCtD
Timolol—Dermatitis—Dexamethasone—psoriasis	7.94e-05	0.000177	CcSEcCtD
Timolol—Dermatitis—Betamethasone—psoriasis	7.94e-05	0.000177	CcSEcCtD
Timolol—Gastrointestinal disorder—Methotrexate—psoriasis	7.92e-05	0.000177	CcSEcCtD
Timolol—Fatigue—Methotrexate—psoriasis	7.91e-05	0.000177	CcSEcCtD
Timolol—Headache—Dexamethasone—psoriasis	7.9e-05	0.000176	CcSEcCtD
Timolol—Headache—Betamethasone—psoriasis	7.9e-05	0.000176	CcSEcCtD
Timolol—Asthenia—Prednisone—psoriasis	7.88e-05	0.000176	CcSEcCtD
Timolol—Pain—Methotrexate—psoriasis	7.85e-05	0.000175	CcSEcCtD
Timolol—Pruritus—Prednisone—psoriasis	7.77e-05	0.000173	CcSEcCtD
Timolol—Feeling abnormal—Methotrexate—psoriasis	7.56e-05	0.000169	CcSEcCtD
Timolol—Diarrhoea—Prednisone—psoriasis	7.51e-05	0.000168	CcSEcCtD
Timolol—Gastrointestinal pain—Methotrexate—psoriasis	7.5e-05	0.000168	CcSEcCtD
Timolol—Nausea—Betamethasone—psoriasis	7.49e-05	0.000167	CcSEcCtD
Timolol—Nausea—Dexamethasone—psoriasis	7.49e-05	0.000167	CcSEcCtD
Timolol—Urticaria—Methotrexate—psoriasis	7.29e-05	0.000163	CcSEcCtD
Timolol—Dizziness—Prednisone—psoriasis	7.26e-05	0.000162	CcSEcCtD
Timolol—Body temperature increased—Methotrexate—psoriasis	7.25e-05	0.000162	CcSEcCtD
Timolol—Abdominal pain—Methotrexate—psoriasis	7.25e-05	0.000162	CcSEcCtD
Timolol—Vomiting—Prednisone—psoriasis	6.98e-05	0.000156	CcSEcCtD
Timolol—Rash—Prednisone—psoriasis	6.92e-05	0.000155	CcSEcCtD
Timolol—Dermatitis—Prednisone—psoriasis	6.91e-05	0.000154	CcSEcCtD
Timolol—Headache—Prednisone—psoriasis	6.88e-05	0.000154	CcSEcCtD
Timolol—Hypersensitivity—Methotrexate—psoriasis	6.76e-05	0.000151	CcSEcCtD
Timolol—Asthenia—Methotrexate—psoriasis	6.58e-05	0.000147	CcSEcCtD
Timolol—Nausea—Prednisone—psoriasis	6.52e-05	0.000146	CcSEcCtD
Timolol—Pruritus—Methotrexate—psoriasis	6.49e-05	0.000145	CcSEcCtD
Timolol—Diarrhoea—Methotrexate—psoriasis	6.28e-05	0.00014	CcSEcCtD
Timolol—Dizziness—Methotrexate—psoriasis	6.07e-05	0.000135	CcSEcCtD
Timolol—ADRB3—Calcium Regulation in the Cardiac Cell—GJB2—psoriasis	6.03e-05	0.0267	CbGpPWpGaD
Timolol—Vomiting—Methotrexate—psoriasis	5.83e-05	0.00013	CcSEcCtD
Timolol—Rash—Methotrexate—psoriasis	5.78e-05	0.000129	CcSEcCtD
Timolol—Dermatitis—Methotrexate—psoriasis	5.78e-05	0.000129	CcSEcCtD
Timolol—Headache—Methotrexate—psoriasis	5.75e-05	0.000128	CcSEcCtD
Timolol—Nausea—Methotrexate—psoriasis	5.45e-05	0.000122	CcSEcCtD
Timolol—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	4.71e-05	0.0209	CbGpPWpGaD
Timolol—CYP2C19—Oxidation by Cytochrome P450—CYP2S1—psoriasis	4.65e-05	0.0206	CbGpPWpGaD
Timolol—ADRB3—Class A/1 (Rhodopsin-like receptors)—HCAR2—psoriasis	4.4e-05	0.0195	CbGpPWpGaD
Timolol—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	4.33e-05	0.0192	CbGpPWpGaD
Timolol—CYP2D6—Oxidation by Cytochrome P450—CYP2S1—psoriasis	4.28e-05	0.0189	CbGpPWpGaD
Timolol—CYP2C19—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	3.82e-05	0.0169	CbGpPWpGaD
Timolol—ADRB1—Melatonin metabolism and effects—APOE—psoriasis	3.69e-05	0.0164	CbGpPWpGaD
Timolol—ABCB1—Drug Induction of Bile Acid Pathway—VDR—psoriasis	3.68e-05	0.0163	CbGpPWpGaD
Timolol—ADRB1—Calcium Regulation in the Cardiac Cell—GJB2—psoriasis	3.58e-05	0.0159	CbGpPWpGaD
Timolol—CYP2D6—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	3.51e-05	0.0156	CbGpPWpGaD
Timolol—ADRB2—Calcium Regulation in the Cardiac Cell—GJB2—psoriasis	3.5e-05	0.0155	CbGpPWpGaD
Timolol—ADRB3—GPCR ligand binding—HCAR2—psoriasis	3.35e-05	0.0148	CbGpPWpGaD
Timolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—HCAR2—psoriasis	2.61e-05	0.0115	CbGpPWpGaD
Timolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—HCAR2—psoriasis	2.55e-05	0.0113	CbGpPWpGaD
Timolol—ADRB3—Class A/1 (Rhodopsin-like receptors)—CCL20—psoriasis	2.28e-05	0.0101	CbGpPWpGaD
Timolol—ADRB1—Melatonin metabolism and effects—NFKB1—psoriasis	2.2e-05	0.00972	CbGpPWpGaD
Timolol—ABCB1—HIF-1-alpha transcription factor network—CP—psoriasis	2.18e-05	0.00966	CbGpPWpGaD
Timolol—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—psoriasis	2.11e-05	0.00935	CbGpPWpGaD
Timolol—CYP2C19—Biological oxidations—CYP2S1—psoriasis	2.03e-05	0.00898	CbGpPWpGaD
Timolol—CYP2C19—Metapathway biotransformation—CYP2S1—psoriasis	2e-05	0.00886	CbGpPWpGaD
Timolol—ADRB1—GPCR ligand binding—HCAR2—psoriasis	1.99e-05	0.0088	CbGpPWpGaD
Timolol—CYP2C19—Melatonin metabolism and effects—APOE—psoriasis	1.97e-05	0.00871	CbGpPWpGaD
Timolol—ADRB2—GPCR ligand binding—HCAR2—psoriasis	1.94e-05	0.0086	CbGpPWpGaD
Timolol—ADRB3—GPCR downstream signaling—HCAR2—psoriasis	1.89e-05	0.00837	CbGpPWpGaD
Timolol—CYP2D6—Biological oxidations—CYP2S1—psoriasis	1.87e-05	0.00826	CbGpPWpGaD
Timolol—CYP2D6—Metapathway biotransformation—CYP2S1—psoriasis	1.84e-05	0.00815	CbGpPWpGaD
Timolol—CYP2D6—Melatonin metabolism and effects—APOE—psoriasis	1.81e-05	0.00801	CbGpPWpGaD
Timolol—ADRB3—GPCR ligand binding—CCL20—psoriasis	1.74e-05	0.0077	CbGpPWpGaD
Timolol—ADRB3—Signaling by GPCR—HCAR2—psoriasis	1.72e-05	0.0076	CbGpPWpGaD
Timolol—ABCB1—Allograft Rejection—HLA-C—psoriasis	1.68e-05	0.00745	CbGpPWpGaD
Timolol—ABCB1—Allograft Rejection—IL13—psoriasis	1.67e-05	0.00741	CbGpPWpGaD
Timolol—ABCB1—Allograft Rejection—IL17A—psoriasis	1.54e-05	0.00682	CbGpPWpGaD
Timolol—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	1.47e-05	0.00652	CbGpPWpGaD
Timolol—ABCB1—Allograft Rejection—IL12B—psoriasis	1.43e-05	0.00634	CbGpPWpGaD
Timolol—ABCB1—Allograft Rejection—HLA-E—psoriasis	1.4e-05	0.00619	CbGpPWpGaD
Timolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—CCL20—psoriasis	1.36e-05	0.006	CbGpPWpGaD
Timolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—CCL20—psoriasis	1.33e-05	0.00587	CbGpPWpGaD
Timolol—CYP2C19—Melatonin metabolism and effects—NFKB1—psoriasis	1.17e-05	0.00518	CbGpPWpGaD
Timolol—ABCB1—Integrated Pancreatic Cancer Pathway—PTTG1—psoriasis	1.16e-05	0.00512	CbGpPWpGaD
Timolol—ADRB1—GPCR downstream signaling—HCAR2—psoriasis	1.12e-05	0.00497	CbGpPWpGaD
Timolol—ADRB2—GPCR downstream signaling—HCAR2—psoriasis	1.1e-05	0.00486	CbGpPWpGaD
Timolol—CYP2D6—Melatonin metabolism and effects—NFKB1—psoriasis	1.08e-05	0.00476	CbGpPWpGaD
Timolol—ABCB1—Allograft Rejection—IL10—psoriasis	1.05e-05	0.00463	CbGpPWpGaD
Timolol—ADRB1—GPCR ligand binding—CCL20—psoriasis	1.03e-05	0.00457	CbGpPWpGaD
Timolol—ADRB1—Signaling by GPCR—HCAR2—psoriasis	1.02e-05	0.00451	CbGpPWpGaD
Timolol—ABCB1—Allograft Rejection—IL4—psoriasis	1.02e-05	0.00451	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—HCAR2—psoriasis	1.01e-05	0.00449	CbGpPWpGaD
Timolol—ADRB2—GPCR ligand binding—CCL20—psoriasis	1.01e-05	0.00447	CbGpPWpGaD
Timolol—ADRB2—Signaling by GPCR—HCAR2—psoriasis	9.97e-06	0.00442	CbGpPWpGaD
Timolol—ABCB1—Allograft Rejection—HLA-B—psoriasis	9.96e-06	0.00441	CbGpPWpGaD
Timolol—ABCB1—HIF-1-alpha transcription factor network—LEP—psoriasis	9.94e-06	0.0044	CbGpPWpGaD
Timolol—ADRB3—GPCR downstream signaling—CCL20—psoriasis	9.83e-06	0.00435	CbGpPWpGaD
Timolol—ABCB1—HIF-1-alpha transcription factor network—NOS2—psoriasis	9.27e-06	0.0041	CbGpPWpGaD
Timolol—ABCB1—Allograft Rejection—HLA-A—psoriasis	9.22e-06	0.00408	CbGpPWpGaD
Timolol—ADRB3—Signaling by GPCR—CCL20—psoriasis	8.92e-06	0.00395	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—TAGAP—psoriasis	8.8e-06	0.0039	CbGpPWpGaD
Timolol—ABCB1—Allograft Rejection—HLA-DRB1—psoriasis	8.43e-06	0.00373	CbGpPWpGaD
Timolol—ADRB3—Class A/1 (Rhodopsin-like receptors)—CXCL8—psoriasis	6.17e-06	0.00273	CbGpPWpGaD
Timolol—ABCB1—Allograft Rejection—IFNG—psoriasis	6.15e-06	0.00272	CbGpPWpGaD
Timolol—ABCB1—HIF-1-alpha transcription factor network—JUN—psoriasis	6.14e-06	0.00272	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—HCAR2—psoriasis	6.02e-06	0.00267	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—HCAR2—psoriasis	5.89e-06	0.00261	CbGpPWpGaD
Timolol—ADRB1—GPCR downstream signaling—CCL20—psoriasis	5.83e-06	0.00258	CbGpPWpGaD
Timolol—ABCB1—Allograft Rejection—CXCL8—psoriasis	5.72e-06	0.00253	CbGpPWpGaD
Timolol—ADRB2—GPCR downstream signaling—CCL20—psoriasis	5.7e-06	0.00253	CbGpPWpGaD
Timolol—ABCB1—HIF-1-alpha transcription factor network—VEGFA—psoriasis	5.37e-06	0.00238	CbGpPWpGaD
Timolol—ADRB1—Signaling by GPCR—CCL20—psoriasis	5.3e-06	0.00234	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—CCL20—psoriasis	5.27e-06	0.00233	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—TAGAP—psoriasis	5.22e-06	0.00231	CbGpPWpGaD
Timolol—ADRB2—Signaling by GPCR—CCL20—psoriasis	5.18e-06	0.00229	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—TAGAP—psoriasis	5.11e-06	0.00226	CbGpPWpGaD
Timolol—ABCB1—Integrated Pancreatic Cancer Pathway—PCNA—psoriasis	4.71e-06	0.00209	CbGpPWpGaD
Timolol—ADRB3—GPCR ligand binding—CXCL8—psoriasis	4.69e-06	0.00208	CbGpPWpGaD
Timolol—ABCB1—Allograft Rejection—VEGFA—psoriasis	4.65e-06	0.00206	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—NDUFA5—psoriasis	4.08e-06	0.00181	CbGpPWpGaD
Timolol—ABCB1—Allograft Rejection—TNF—psoriasis	3.98e-06	0.00176	CbGpPWpGaD
Timolol—ABCB1—Metabolism—NDUFA5—psoriasis	3.98e-06	0.00176	CbGpPWpGaD
Timolol—ABCB1—Integrated Pancreatic Cancer Pathway—NFKBIA—psoriasis	3.96e-06	0.00175	CbGpPWpGaD
Timolol—CYP2C19—Metabolism of lipids and lipoproteins—CARM1—psoriasis	3.8e-06	0.00168	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—NDUFA5—psoriasis	3.75e-06	0.00166	CbGpPWpGaD
Timolol—ABCB1—Transmembrane transport of small molecules—CP—psoriasis	3.7e-06	0.00164	CbGpPWpGaD
Timolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—CXCL8—psoriasis	3.66e-06	0.00162	CbGpPWpGaD
Timolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—CXCL8—psoriasis	3.58e-06	0.00158	CbGpPWpGaD
Timolol—ABCB1—Transmembrane transport of small molecules—CARM1—psoriasis	3.53e-06	0.00156	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—CYP2S1—psoriasis	3.47e-06	0.00154	CbGpPWpGaD
Timolol—ABCB1—Metabolism—CYP2S1—psoriasis	3.39e-06	0.0015	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—CYP2S1—psoriasis	3.19e-06	0.00141	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—CCL20—psoriasis	3.13e-06	0.00138	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—CCL20—psoriasis	3.06e-06	0.00135	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—SOCS1—psoriasis	2.9e-06	0.00128	CbGpPWpGaD
Timolol—ADRB1—GPCR ligand binding—CXCL8—psoriasis	2.79e-06	0.00123	CbGpPWpGaD
Timolol—ADRB3—Signaling by GPCR—TYK2—psoriasis	2.77e-06	0.00123	CbGpPWpGaD
Timolol—ADRB2—GPCR ligand binding—CXCL8—psoriasis	2.73e-06	0.00121	CbGpPWpGaD
Timolol—ADRB3—GPCR downstream signaling—CXCL8—psoriasis	2.65e-06	0.00117	CbGpPWpGaD
Timolol—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—psoriasis	2.63e-06	0.00116	CbGpPWpGaD
Timolol—ABCB1—Integrated Pancreatic Cancer Pathway—NFKB1—psoriasis	2.53e-06	0.00112	CbGpPWpGaD
Timolol—ADRB3—Signaling by GPCR—CXCL8—psoriasis	2.41e-06	0.00107	CbGpPWpGaD
Timolol—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—psoriasis	2.29e-06	0.00102	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—LEP—psoriasis	2.14e-06	0.000948	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—APOE—psoriasis	2.14e-06	0.000948	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—NFKBIA—psoriasis	2e-06	0.000884	CbGpPWpGaD
Timolol—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—psoriasis	1.97e-06	0.00087	CbGpPWpGaD
Timolol—CYP2C19—Metabolism of lipids and lipoproteins—APOE—psoriasis	1.82e-06	0.000805	CbGpPWpGaD
Timolol—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—psoriasis	1.73e-06	0.000767	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—SOCS1—psoriasis	1.72e-06	0.000763	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—CARM1—psoriasis	1.69e-06	0.00075	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—SOCS1—psoriasis	1.69e-06	0.000746	CbGpPWpGaD
Timolol—ABCB1—Metabolism—CARM1—psoriasis	1.65e-06	0.000732	CbGpPWpGaD
Timolol—ADRB1—Signaling by GPCR—TYK2—psoriasis	1.64e-06	0.000727	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—TYK2—psoriasis	1.63e-06	0.000724	CbGpPWpGaD
Timolol—ADRB2—Signaling by GPCR—TYK2—psoriasis	1.61e-06	0.000711	CbGpPWpGaD
Timolol—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—psoriasis	1.58e-06	0.000701	CbGpPWpGaD
Timolol—ADRB1—GPCR downstream signaling—CXCL8—psoriasis	1.57e-06	0.000697	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—CARM1—psoriasis	1.56e-06	0.00069	CbGpPWpGaD
Timolol—ADRB2—GPCR downstream signaling—CXCL8—psoriasis	1.54e-06	0.000682	CbGpPWpGaD
Timolol—ADRB1—Signaling by GPCR—CXCL8—psoriasis	1.43e-06	0.000633	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—CXCL8—psoriasis	1.42e-06	0.00063	CbGpPWpGaD
Timolol—ADRB2—Signaling by GPCR—CXCL8—psoriasis	1.4e-06	0.000619	CbGpPWpGaD
Timolol—ADRB3—Signaling by GPCR—IL6—psoriasis	1.35e-06	0.000599	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—JUN—psoriasis	1.32e-06	0.000586	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—NFKB1—psoriasis	1.27e-06	0.000564	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—LEP—psoriasis	1.27e-06	0.000563	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—APOE—psoriasis	1.27e-06	0.000563	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—LEP—psoriasis	1.24e-06	0.000551	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—APOE—psoriasis	1.24e-06	0.000551	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—NFKBIA—psoriasis	1.18e-06	0.000524	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—NFKBIA—psoriasis	1.16e-06	0.000513	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—VEGFA—psoriasis	1.16e-06	0.000512	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—STAT3—psoriasis	1.14e-06	0.000507	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—CAT—psoriasis	1.04e-06	0.000461	CbGpPWpGaD
Timolol—ABCB1—Metabolism—CAT—psoriasis	1.02e-06	0.00045	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—TYK2—psoriasis	9.7e-07	0.00043	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—CAT—psoriasis	9.59e-07	0.000424	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—TYK2—psoriasis	9.49e-07	0.00042	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—TP53—psoriasis	8.73e-07	0.000387	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—CXCL8—psoriasis	8.45e-07	0.000374	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—CXCL8—psoriasis	8.26e-07	0.000366	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—APOE—psoriasis	8.1e-07	0.000358	CbGpPWpGaD
Timolol—ADRB1—Signaling by GPCR—IL6—psoriasis	8.03e-07	0.000356	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—IL6—psoriasis	8e-07	0.000354	CbGpPWpGaD
Timolol—ABCB1—Metabolism—APOE—psoriasis	7.9e-07	0.00035	CbGpPWpGaD
Timolol—ADRB2—Signaling by GPCR—IL6—psoriasis	7.86e-07	0.000348	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—JUN—psoriasis	7.85e-07	0.000348	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—JUN—psoriasis	7.68e-07	0.00034	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—NFKB1—psoriasis	7.56e-07	0.000335	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—APOE—psoriasis	7.45e-07	0.00033	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—NFKB1—psoriasis	7.4e-07	0.000327	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—PPARG—psoriasis	7.05e-07	0.000312	CbGpPWpGaD
Timolol—ABCB1—Metabolism—PPARG—psoriasis	6.88e-07	0.000305	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—VEGFA—psoriasis	6.86e-07	0.000304	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—STAT3—psoriasis	6.79e-07	0.000301	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—VEGFA—psoriasis	6.71e-07	0.000297	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—STAT3—psoriasis	6.65e-07	0.000294	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—PPARG—psoriasis	6.49e-07	0.000287	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—TP53—psoriasis	5.18e-07	0.00023	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—TP53—psoriasis	5.07e-07	0.000225	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—IL6—psoriasis	4.75e-07	0.00021	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—IL6—psoriasis	4.64e-07	0.000206	CbGpPWpGaD
